The NPPA has revised prices for 137 non-scheduled anti-cancer drugs after capping trade margins at 30 per cent. Effective November 9, the measure is expected to reduce prices by up to 70 per cent and ease treatment costs. Hyderabad: For cancer patients struggling with the crushing financial toll of oncology wards, a cancer drug that once cost Rs 28,000 will soon cost under Rs 5,000.